{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"55.1","upperLimit":"91.2","value":"73.1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"}],"units":"Participants"}],"description":"Kaplan-Meier curves of EFS will be plotted, and the proportion of responders to induction therapy will be tabulated.","dispersionType":"95% Confidence Interval","groups":[{"description":"Induction therapy + single myeloablative consolidation","id":"OG000","title":"Single HST (CEM)"}],"paramType":"NUMBER","populationDescription":"All eligible patients non-randomly assigned to single CEM","reportingStatus":"POSTED","timeFrame":"Up to 3 years","title":"EFS Pts Non-randomly Assigned to Single CEM (12-18 Mths, Stg. 4, MYCN Nonamplified Tumor/Unfavorable or Indeterminant Histopathology/Diploid DNA Content & Pts>547 Days, Stg.3, MYCN Nonamplified Tumor AND Unfavorable or Indeterminant Histopathology).","type":"SECONDARY","unitOfMeasure":"percent probability"}